In the third year of the pandemic, mRNA specialist Moderna is marshaling one of its tried-and-true manufacturing partners to lock up production of its COVID shot for years to come. Moderna and Thermo ...

Moderna Inc has entered into a long-term agreement with Thermo Fisher Scientific for the manufacturing of its COVID-19 vaccine and other experimental medicines based on mRNA technology, the companies ...

Vaxcyte (NASDAQ:PCVX) announced a long-term agreement worth up to $1B with Thermo Fisher Scientific (NYSE:TMO) on Tuesday to support the future commercial production of its pneumonia vaccines. Under ...

MINNEAPOLIS--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, is showcasing new instruments, workflows, software and industry collaborations that enable ...

WILMINGTON, N.C.--(BUSINESS WIRE)--The PPD clinical research business of Thermo Fisher Scientific was named “Best Contract Research Organization” at the 15 th annual Vaccine Industry Excellence (ViE) ...

Thermo Fisher didn’t just come out of the toughest year for the global economy unscathed, the company managed to deliver its best year ever despite challenges around the economy and spending budgets.

Feb 23 (Reuters) - Moderna Inc (MRNA.O), opens new tab has entered into a long-term agreement with Thermo Fisher Scientific (TMO.N), opens new tab for the manufacturing of its COVID-19 vaccine and ...